The most recognized and widely-used case definitions (Fukuda [13] and Canadian Consensus criteria [1]) are based on self-reported symptoms. Studies of energy metabolism, oxidative stress and immunological alterations in ME/CFS have demonstrated imbalance in all these pathways, but the use of such information for diagnostic purposes is still far from reality.
Here, HERV-K and W transcripts were detected in all groups investigated, and we found that HERV-K was overexpressed in moderate ME/CFS. It is possible that the immunological, genic expression and metabolic alterations are different according to disease severity.
The interplay between endogenous retroviruses and the immune system is complex. ERVs are part of the host genome and in theory, they are supposed to be recognized as self-antigens and an immune tolerance should be established during the early stages of the organism development [14]. However, HERV products can interact with components of the innate immune system leading to the activation of pro-inflammatory pathways or, in some particular cases, their suppression [15]. The syncytin-2 protein for example, is a product of the ERV-FRD Env gene that has an immunosuppressive role by preventing maternal immune response against the fetus [16]. In a distinct scenario, it was demonstrated using psoriasis model that a pro-inflammatory environment could be able to suppress the expression of repetitive elements, including HERVs [17]. It would be reasonable to suggest that the immunological enhancement seen in more severe ME/CFS works by silencing the HERV transactivation that occurs in moderate cases. Such transactivation could be caused by exogenous viral replication or another as yet unknown factor. In line with this, Montoya and colleagues found a cytokine signature of severity in people with ME/CFS [18]. They demonstrated that from the 17 cytokines related to severity, 13 are pro-inflammatory, and (in addition to the worsening of the symptoms) may cause the reversion of the HERV-K activity to levels similar to those seen in healthy individuals. It may similarly occur with HERV-W, which, despite not being at significant levels, there was a slight decrease in people severely affected by ME/CFS when compared to those who are moderately affected.
Infection has often been considered as a trigger to ME/CFS. Many patients report that the fatigue began during or short after an episode of infectious disease. A number of pathogens including viruses have been associated with this disease [3]. And, due to its life long persistence and broad cell tropism, the herpesviridae family, particularly HHV-6 has been considered to be a possible trigger for ME/CFS for many, even though such relationship has not been consistent [3, 9]. Interestingly, HHV-6 as some other herpesviruses, is also capable of transactivating HERVs, particularly, HERV-K [6]. Such transactivation may be either direct (through LTR activation by viral products) or indirect (via transcriptional binding factors and cytokines produced by viral replication) [3, 6]. It is possible that as the disease progresses, whatever the exogenous infection that would have act as the trigger factor is controlled, and consequently, the HERVs transactivation decrease. Unfortunately, we did not perform serological or molecular tests for exogenous viruses.
Two reports of HERV activity in ME/CFS were published some years ago but the results were conflicting. In 2013 Oakes and his team found no difference on the expression of HERV-K18 envelope in people with ME/CFS when compared with HCs [9]. In the same year De Meirleir and colleagues, using immunohistochemical methods, found immunoreactivity to HERV proteins (HERV-K, HERV-18, HERV-R and HERV-FRD) in dendritic cells of the duodenum of individuals diagnosed with the syndrome [10], suggesting that alterations in endogenous retroviruses expression pattern may occur in ME/CFS. The differences between the results of Oakes and colleagues and ours may be due to the methods used to detect HERV-K. While the present work used generic primers for HERV-K that allow the detection of hundreds of elements from most HML subfamilies the Oakes team searched for the HERV-K 18 envelope transcripts only, using a method specific to this particular element, while neglecting all the remaining proviruses from the K family. On the other hand, we are unable to determine which K family proviruses are involved in the differential expression observed.
The molecular method used here to detect HERV-W was also generic and was widely used in several studies that found differential expression of this element in pathological conditions, including in the blood, brain and CSF of multiple sclerosis (MS) patients [19]. Therefore, despite the similarity of a number of symptoms and the strong immunological component of ME/CFS and MS, the mechanisms responsible for HERV reactivation in such diseases are likely distinct.